Schimpff Sc

457 total citations
11 papers, 357 citations indexed

About

Schimpff Sc is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Schimpff Sc has authored 11 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Schimpff Sc's work include Neutropenia and Cancer Infections (5 papers), Hematological disorders and diagnostics (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Schimpff Sc is often cited by papers focused on Neutropenia and Cancer Infections (5 papers), Hematological disorders and diagnostics (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Schimpff Sc collaborates with scholars based in . Schimpff Sc's co-authors include Young Rc, Levine As, Graw Rg, Joseph Aisner, Pizzo Pa and Wiernik Ph and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Schimpff Sc

11 papers receiving 262 citations

Peers

Schimpff Sc
Comparison fields: 5 of 60
  • Oncology 229
  • Epidemiology 113
  • Pulmonary and Respiratory Medicine 78
  • Infectious Diseases 75
  • Clinical Biochemistry 73
Replace Graw Rg with:
Graw Rg
B. Lank Canada
Carlos A. De Jongh United States
Deborah Cotton United States
Mark Hastings United Kingdom
T. Schmeiser Germany
F. Wendt Germany
F. Menichetti Italy
O Kellner Germany
Isabelle Tkaczewski United States
Citations per field, relative to Schimpff Sc
Schimpff Sc · 1×
Citations per year, relative to Schimpff Sc
Schimpff Sc · 1×

Countries citing papers authored by Schimpff Sc

Since Specialization
Citations

This map shows the geographic impact of Schimpff Sc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Schimpff Sc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Schimpff Sc more than expected).

Fields of papers citing papers by Schimpff Sc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Schimpff Sc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Schimpff Sc. The network helps show where Schimpff Sc may publish in the future.

Co-authorship network of co-authors of Schimpff Sc

This figure shows the co-authorship network connecting the top 25 collaborators of Schimpff Sc. A scholar is included among the top collaborators of Schimpff Sc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Schimpff Sc. Schimpff Sc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
# Work Indexed citations
1
Dual lumen catheters for angioaccess in patients with leukemia.
3
2
Strategies for the prevention of infection in the myelosuppressed or immunosuppressed cancer patient.
31
3
Rifampin and cloxacillin in the reduction of Staphylococcus aureus colonization.
1
4
Empiric antibiotic therapy for granulocytopenic patients.
15
5
A comparative trial of tobramycin vs gentamicin in combination with vancomycin and nystatin for alimentary tract suppression in leukemic patients.
11
6
In vitro antibacterial activity of four aminoglycosides and two semisynthetic penicillins on fresh clinical isolates from cancer patients.
3
7
Empiric antibiotic therapy.
41
8
Schimpff tells prevention strategies.
1
9
Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin.
9
10
Evaluation of radiotherapay for localized inflammatory skin and perianal lesions in adult leukemia: A porspectively randomized double blind study.
6
11
Hematologic malignancies and other marrow failure states: progress in the management of complicating infections.
236

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026